Efficacy of p16 and Ki67 immunostaining in the detection of squamous intraepithelial lesions in a highrisk HPV group

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1447-1452

Spandidos Publications

Access to resources Recommend Favorite

Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach to Immunotherapy of Cervical Cancer

By Schoell W.M.J.   Mirhashemi R.   Liu B.   Janicek M.F.   Podack E.R.   Penalver M.A.   Averette H.E.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 448-455

Elsevier

Access to resources Recommend Favorite

G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value*

By Cho N.H.   Lim S.Y.   Kim Y.T.   Kim D.   Kim Y.S.   Kim J.W.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 15-22

Elsevier

Access to resources Recommend Favorite

Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation

By Huang H.   Li C.-Y.   Little J. B.  

International Journal of Radiation Biology, Vol. 70, Iss. 2, 1996-08 ,pp. : 151-160

Informa Healthcare

Access to resources Recommend Favorite

Significant Difference in p53 and p21 Protein Immunoreactivity in HPV 16 Positive and HPV Negative Breast Carcinomas

By Hennig Elin M.   Kvinnsland Stener   Holm Ruth   Nesland Jahn M.  

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite